Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer

Journal of Clinical Oncology

Volumn 27, Issue 15, 2009, Pages 2466-2473

  Anderson, Stewart J ^a   Wapnir, Irene ^a   Dignam, James J ^a   Fisher, Bernard ^a   Mamounas, Eleftherios P ^a   Jeong, Jong Hyeon ^a   Geyer Jr , Charles E ^a   Wickerham, D Lawrence ^a   Costantino, Joseph P ^a   Wolmark, Norman ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE INTERVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; AGED; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; STATISTICS; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY;

EID: 66349105317     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.8424     Document Type: Article

References (44)

1. Fisher B, Anderson S, Fisher ER, et al: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331, 1991
2. Haffty B, Fischer D, Beinfield M, et al: Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 21:293-298, 1991
3. Fisher ER, Anderson S, Redmond C, et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 8:161-166, 1992
4. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
5. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996 (Pubitemid 26019996)
6. Fortin A, Larochelle M, Laverdière J, et al: Local failure is responsible for the decrease in survival of patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17:101-109, 1999 (Pubitemid 29022383)
7. Elkhuizen PH, van Slooten HJ, Clahsen PC, et al: High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 18: 1075-1083, 2000
8. Taghian A, Jeong JH, Mamounas E, et al: Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22:4247-4254, 2004 (Pubitemid 41185145)
9. Wapnir IL, Anderson SJ, Mamounas EP, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028-2037, 2006
10. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985 (Pubitemid 15134702)
11. Fisher B, Anderson S, Redmond C, et al: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy to lumpectomy with and without irradiation in the treatment of breast cancer. N Engl J Med 333:1456-1461, 1995
12. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002 (Pubitemid 35176242)
13. Fisher B, Redmond C, Dimitrov NV, et al: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:473-478, 1989 (Pubitemid 19062521)
14. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484, 1989 (Pubitemid 19062522)
15. Fisher B, Dignam J, Bryant J, et al: Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 88:1529-1542, 1996 (Pubitemid 26374506)
16. Fisher B, Dignam J, Mamounas EP, et al: Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14:1982-1992, 1996
17. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89:1673-1682, 1997 (Pubitemid 27508191)
18. Fisher B, Anderson S, Tan-Chiu E, et al: Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol 19:931-942, 2001 (Pubitemid 32176267)
19. Fisher B, Jeong JH, Bryant J, et al: Treatment of lymph node-negative, estrogen receptor-positive breast cancer: Long-term findings from National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Lancet 364:858-868, 2004
20. Fisher B, Jeong JH, Anderson S, et al: Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: Updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. J Natl Cancer Inst 96:1823-1831, 2004
21. Gaynor JJ, Feuer EJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Stat Assoc 88:400-409, 1993
22. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
23. Klein JP, Moeschberger ML: Survival Analysis: Techniques for Censored and Truncated Data. Springer-Verlag, New York, NY, 1997, pp 251-259, 271-282
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. Gail MH: Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 37:67-78, 1981
26. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
27. Albain KS: Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: A tale of three trials. J Natl Cancer Inst 96:1801-1804, 2004
28. Voogd AC, van Oost FJ, Rutgers EJ, et al: Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41:2637-2644, 2005 (Pubitemid 41607554)
29. Galper S, Blood E, Gelman R, et al: Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. Int J Radiat Oncol Biol Phys 61:348-357, 2005 (Pubitemid 40164426)
30. Pierce L, Fowble B, Solin LJ, et al: Conservative surgery and radiation therapy in black women with early stage breast cancer. Cancer 69:2831-2841, 1992
31. Connor CS, Touijer AK, Krishnan L, et al: Local recurrence following breast conservation therapy in African-American women with invasive breast cancer. Am J Surg 179:22-26, 2000 (Pubitemid 30126004)
32. Srokowski TP, Fang S, Duan Z, et al: Completion of adjuvant radiation therapy among women with breast cancer. Cancer 113:22-29, 2008 (Pubitemid 351976382)
33. Dignam JJ: Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr 36-43, 2001
34. Dignam JJ, Wieand K, Johnson KA, et al: Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467-1476, 2003 (Pubitemid 37279332)
35. Dignam JJ, Wieand K, Johnson KA, et al: Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat 97:245-254, 2006 (Pubitemid 43948218)
36. Whelan T, Clark R, Roberts R, et al: Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 30:11-16, 1994
37. van der Sangen MJ, van de Poll-Franse LV, Roumen RM, et al: The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol 32:34-38, 2006
38. Smith TE, Lee D, Turner BC, et al: True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48:1281-1289, 2000 (Pubitemid 30838354)
39. Huang E, Buchholz TA, Meric F, et al: Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95:2059-2067, 2002 (Pubitemid 35253366)
40. Kuerer HM, Arthur DW, Haffty BG: Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: The potential role of partial breast irradiation. Cancer 100:2269-2280, 2004
41. Kurtz JM, Amalric R, Brandone H, et al: Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer 61:1969-1972, 1988
42. Alpert TE, Kuerer HM, Arthur DW, et al: Ipsilateral breast tumor recurrence after breast conservation therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 63:845-851, 2005
43. Trombetta M, Julian T, Bhandari T, et al: Breast conservation surgery and interstitial brachy-therapy in the management of locally recurrent carcinoma of the breast: The Allegheny General Hospital experience. Brachytherapy 7:29-36, 2008
44. Wapnir IL, Aebi S, Geyer CE, et al: A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, AND NSABP B-37. Clin Breast Cancer 8:287-292, 2008